Protocol for the simultaneous activation and lentiviral transduction of primary human T cells with artificial T cell receptors
- STAR Protoc. 2025 Mar 21;6(1):103685. doi: 10.1016/j.xpro.2025.103685.
- 1. Department of Pharmacy & Pharmaceutical Sciences, Faculty of Science, National University of Singapore, 18 Science Drive 2, Singapore 117543, Singapore. Electronic address: [email protected].
- 2. Department of Microbiology & Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, Singapore 117545, Singapore; Immunology Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, Singapore 117545, Singapore; Cancer Translational Research Programme, Yong Loo Lin School School of Medicine, National University of Singapore, 5 Science Drive 2, Singapore 117545, Singapore.
- 3. Department of Pharmacy & Pharmaceutical Sciences, Faculty of Science, National University of Singapore, 18 Science Drive 2, Singapore 117543, Singapore.
- 4. Department of Pharmacy & Pharmaceutical Sciences, Faculty of Science, National University of Singapore, 18 Science Drive 2, Singapore 117543, Singapore. Electronic address: [email protected].
T cell-based therapies hold immense promise, but their production remains time-consuming and technically complex. Here, we present a protocol that streamlines the activation and lentiviral transduction of primary human T cells with artificial receptors. We describe steps for T Cell Isolation, lentivirus production, and the simultaneous activation/transduction of T cells. By eliminating magnetic T cell activation beads, sequential steps, and lengthy spinoculation, this protocol significantly enhances efficiency, scalability, and accessibility for research and therapeutic applications.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Biochemical Assay ReagentsResearch Areas: Cancer